Icon leveraging EMRs of 57m patients

By Melissa Fassbender contact

- Last updated on GMT

(Image: iStock/tarasov_vl)
(Image: iStock/tarasov_vl)

Related tags: Clinical trial

TriNetX, a research network and technology platform, connects Icon to the electronic medical records (EMRs) of 57m patients across the globe.

TriNetX offers robust query and analytics tools that enable real-time analyses of patient populations which are helping our customers design better protocols, select the right sites and recruit patients faster​,” Lars Olof Eriksson, EVP Site and Patient Recruitment at Icon, told Outsourcing-Pharma.com.

Through the combination of resources, Eriksson said the companies will “disrupt the clinical trial design space by unleashing the power of data and apply it in a pragmatic and effective way to overcome complex clinical development challenges.​”

Read: Accelerating the clinical development process with EMRs

To date, Icon has already conducted more than 300 feasibility reviews using TriNetX to analyze patient populations with search criteria across several data points and assess various inclusion and exclusion criteria.

According to the company, each data point in the TriNetX system can then be traced to healthcare organizations who are able to identify individual patients.

As Outsorucing-Pharma.com previously reported, Icon’s patient recruitment capabilities were also strengthened through its acquisition​ of PMG Research last year.  

Related news

Show more

Related products

show more

What do big pharma companies spend on R&D?

What do big pharma companies spend on R&D?

Zymewire | 15-Aug-2019 | Technical / White Paper

The free Big Pharma R&D Spend report examines the financial performance and research & development investments of the top 25 pharmaceutical companies...

Related suppliers

Follow us

Products

View more

Webinars